Cartesian Therapeutics, Inc. RNAC
6.89 USD -0.13 (-1.85%)
At closeNov 10, 2026, 4:00 PM EST
6.80 -0.09 -1.31%
After hours · Nov 10, 4:00 PM ET
6.76 Day range 7.28
5.60 52-week range 11.00
- YTD
- -4.44%
- 1 year
- -4.83%
News
zacks.com Wall Street Analysts See a 379.63% Upside in Cartesian Therapeutics, Inc. (RNAC): Can the Stock Really Move This High? The consensus price target hints at a 379.6% upside potential for Cartesian Therapeutics, Inc. (RNAC). While empirical research shows that this sought-after metric is hardly effective, an upward…
benzinga.com Cartesian Therapeutics Q3 EPS $(0.38) Beats $(0.95) Estimate Cartesian Therapeutics (NASDAQ:RNAC) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.95) by 60 percent. This is a 72.46 percent increase over losses of…
globenewswire.com Cartesian Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update Phase 3 AURORA trial of Descartes-08 in myasthenia gravis (MG) advances towards data readout expected in 1Q27 and biologics license application (BLA) filing planned for mid-2027 Retreatment data for…